UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
18
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Molina Healthcare, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 29, 2018 – MOH

NEW YORK, June 27, 2018 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE: MOH ) between October 31, 2014 and August 2, 2017 . You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Central District of California. To get more information go to:

http://www.zlk.com/pslra-d/molina-healthcare-inc?wire=3

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Molina's administrative infrastructure was never designed to handle the size and complexity of its rapid growth strategy; and (2) it failed to remediate systemic issues and costly disruptions with critical administrative infrastructure functions, including provider payment and utilization management. On April 28, 2016, Molina reported an earnings miss for the first quarter ended March 31, 2016 and reduced its full-year 2016 earnings guidance. On August 2, 2017, Molina withdrew its 2017 earnings projection, reported a net loss of $230 million for the second quarter ended June 30, 2017, and revealed it would exit certain ACA Health Exchange markets.

If you suffered a loss in Molina Healthcare, Inc. you have until June 29, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com  

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Valneva's Financial Progress and Vaccine Innovations Unveiled

Updated Category News Views 232

Valneva Reports Strong First Quarter Financials Valneva SE, a prominent specialty vaccine company known for its innovative approaches to infectious diseases, recently revealed its financial performance for the first quarter of 2025. The results reflect a significant growth trajectory compared to the same period last year. Financial Highlights In the first quarter of 2025,...

Continue Reading
WAVJA's Innovative Energy System Set to Change Indoor Power

Updated Category News Views 248

WAVJA's Photon Energy System Overview The energy landscape is undergoing significant changes, and WAVJA is at the forefront with its groundbreaking Photon Energy System (PES). This U.S.-based innovation is not just about powering homes; it's revolutionizing how we think about renewable sources of energy. In a time where climate challenges are prevalent, PES transforms the...

Continue Reading
Spinal Innovations: Enrollment Marks New Era for Disc Replacement

Updated Category News Views 257

Spinal Innovations: Enrollment Marks New Era for Disc Replacement Spinal Stabilization Technologies, LLC (SST) is making ground-breaking strides in spinal care with the enrollment of the first patient in the U.S. for its Investigational Device Exemption (IDE) trial. This new phase in clinical research focuses on the PerQdisc Nucleus Replacement Device (NRD), a promising...

Continue Reading
The O2 Achieves Record Ticket Sales and Unforgettable Events

Updated Category News Views 380

The O2 Celebrates a Milestone Year London's O2 arena, the world's leading destination for live entertainment, has recently marked another record-breaking year. In 2024, the venue achieved over 2.6 million ticket sales, reflecting a notable 3.5% increase over the previous year. This success reaffirms The O2's status as a premier location for music, comedy, and sports...

Continue Reading
Wah Fu Education Group Ltd. Revises Annual Meeting Announcement

Updated Category News Views 93

Correction Notice for Wah Fu Education Group Ltd.'s Annual Meeting Wah Fu Education Group Ltd. (NASDAQ: WAFU) has recently issued important corrections regarding its announcement about the upcoming Annual General Meeting (AGM). This notice serves to clarify any potentially misleading information that was communicated in the initial press release sent earlier this month....

Continue Reading